Literature DB >> 11329608

Parenteral nutrition-associated cholestasis.

D H Teitelbaum1, T Tracy.   

Abstract

Cholestasis is a major complication that occurs frequently in patients with the short bowel syndrome and accounts for the majority of morbidity and mortality in this group of patients. The exact cause of this condition is not known and the etiology is likely multifactorial. Many new mechanistic insights into this disease are discussed and have paved the way for future investigation. For now, prompt recognition, early initiation of enteral feeding, prevention of overfeeding with parenteral nutrition, and agents that induce bile flow may be useful to prevent this catastrophic morbidity.

Entities:  

Mesh:

Year:  2001        PMID: 11329608     DOI: 10.1053/spsu.2001.22386

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  17 in total

1.  Histologic changes in neuronal innervation of the ileum mucosa after autologic-allotopic ileum mucosa transplantation.

Authors:  Hans Albert Beiler; Karl-Herbert Schäfer; Cornelia Hagl; Jörn Steinorth; Alexander Witt; Zacharias Zachariou
Journal:  Pediatr Surg Int       Date:  2004-03-11       Impact factor: 1.827

2.  Implementation of a multidisciplinary team approach and fish oil emulsion administration in the management of infants with short bowel syndrome and parenteral nutrition-associated liver disease.

Authors:  Ana M G A Sant'Anna; Eyad Altamimi; Rose-Frances Clause; Joanne Saab; Heather Mileski; Brian Cameron; Peter Fitzgerald; Guilherme M Sant'Anna
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

3.  Alteration of canalicular transporters in a mouse model of total parenteral nutrition.

Authors:  Yuko Tazuke; Daniel H Teitelbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

4.  An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure-Associated Liver Disease in Infants With Intestinal Failure.

Authors:  Christina Belza; John C Wales; Glenda Courtney-Martin; Nicole de Silva; Yaron Avitzur; Paul W Wales
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-25       Impact factor: 4.016

5.  Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.

Authors:  Adam S Brinkman; Sangita G Murali; Stacy Hitt; Patrick M Solverson; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

Review 6.  Short bowel syndrome in children: current and potential therapies.

Authors:  Victor Uko; Kadakkal Radhakrishnan; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

7.  The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.

Authors:  Sabrina E Sanchez; Lindsay P Braun; Laina D Mercer; Meredith Sherrill; Jennifer Stevens; Patrick J Javid
Journal:  J Pediatr Surg       Date:  2013-03       Impact factor: 2.545

Review 8.  New and emerging therapies for short bowel syndrome in children.

Authors:  Jon A Vanderhoof; Rosemary J Young; Jon S Thompson
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates.

Authors:  T Hang Nghiem-Rao; Laura D Cassidy; Elizabeth M Polzin; Casey M Calkins; Marjorie J Arca; Praveen S Goday
Journal:  Nutr Clin Pract       Date:  2013-10-09       Impact factor: 3.080

Review 10.  The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Paul W Wales
Journal:  Pediatr Surg Int       Date:  2008-05-27       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.